Today, Moderna have published in a press release their interim top-line findings looking at antibody responses from their Omicron-containing bivalent COVID-19 vaccine.
Journalists dialled into the briefing to hear from Moderna scientists and ask them questions.
This was interim early data with no paper or preprint.
Dr Philip Cruz, UK Medical Director, Moderna
Dr Paul Burton, Chief Medical Officer, Moderna
This Briefing was accompanied by an SMC Roundup of Comments.